This page shows you your search results in order of date. This is page number 20.
Order by Relevance | Date
Total 442 results found since Jan 2013.
Johnson & Johnson ’ s Ethicon wins FDA nod for expanded Evarrest indication
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon said today it won an expanded indication from the FDA for its Evarrest fibrin sealant patch, now cleared for use as an adjunctive hemostat across a “broad range” of challenging patient types and surgical situations.
The company touted the win as a significant milestone in controlling problematic bleeding situations “with high confidence.”
“I’m usually very conservative when using new products but I think Evarrest stands out as one of those products that has made a difference in our practice. I’ve used Evarrest to manage troubl...
Source: Mass Device - October 25, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Blood Management Food & Drug Administration (FDA) Regulatory/Compliance Surgical Ethicon Johnson & Johnson Source Type: news
“Hemostat forceps” a simple and useful adjuvant to clip applicator forceps for clipping saccular cerebral aneurysms – Technical note
Publication date: December 2016 Source:Interdisciplinary Neurosurgery, Volume 6 Author(s): Mahesh Krishna Pillai, Smitha Thankappan Nair Despite technical and technological advances in Neurosurgery, in the last four decades, there has been no significant reduction, in the dimensions of the, aneurysm clip applicator forceps. This can be challenging, even to the most experienced neurovascular surgeon, especially when the surgical corridor created remains narrow, despite all possible measures to widen it. The author describes one such situation, where an anterior communicating artery aneurysm was clipped successfully using a...
Source: Interdisciplinary Neurosurgery - October 13, 2016 Category: Neurosurgery Source Type: research
A standardized surgical technique for removal of the Interstim tined lead.
CONCLUSION: Permanent tined leads can break on removal and retained fragments can pose significant health consequences. Our technique standardizes the approach for removal and is safe and effective in our series.
PMID: 27705733 [PubMed - in process]
Source: Canadian Journal of Urology - October 10, 2016 Category: Urology & Nephrology Tags: Can J Urol Source Type: research
"Hemostat Forceps" A Simple and Useful Adjuvant to Clip Applicator Forceps for Clipping Saccular Cerebral Aneurysms – Technical note
Publication date: Available online 12 September 2016 Source:Interdisciplinary Neurosurgery Author(s): Mahesh Krishna Pillai Despite technical and technological advances in Neurosurgery, in the last four decades, there has been no significant reduction, in the dimensions of the, aneurysm clip applicator forceps. This can be challenging, even to the most experienced neurovascular surgeon, especially when the surgical corridor created remains narrow, despite all possible measures to widen it. The author describes one such situation, where an anterior communicating artery aneurysm was clipped successfully using a simple “he...
Source: Interdisciplinary Neurosurgery - September 11, 2016 Category: Neurosurgery Source Type: research
Nociceptive and Neuronal Evaluation of the Sciatic Nerve of Wistar Rats Subjected to Compression Injury and Treated with Resistive Exercise.
Conclusion. Climb stairs resistance exercise was not effective to speed up the regenerative process of axons.
PMID: 27594795 [PubMed - in process]
Source: Pain Research and Management - September 8, 2016 Category: Anesthesiology Authors: Antunes JS, Lovison K, Karvat J, Peretti AL, Vieira L, Higuchi GH, Brancalhão RM, Ribeiro Lde F, Bertolini GR Tags: Pain Res Manag Source Type: research
Hydrophobically-Modified Chitosan Gauze: A Novel Topical Hemostat
Currently, the standard of care for treating severe hemorrhage in a military setting is Combat GauzeTM (CG). Previous work has shown that hydrophobically modified chitosan (hm-C) has significant hemostatic capability relative to its native chitosan counterpart. This work aims to evaluate gauze coated in hm-C relative to CG as well as ChitoGauze ® (ChG) in a lethal in vivo hemorrhage model.
Source: Journal of Surgical Research - July 26, 2016 Category: Surgery Authors: Apurva Chaturvedi, Matthew B. Dowling, John P. Gustin, Thomas M. Scalea, Srinivasa R. Raghavan, Jason D. Pasley, Mayur Narayan Source Type: research
Hydrophobically modified chitosan gauze: a novel topical hemostat
Currently, the standard of care for treating severe hemorrhage in a military setting is Combat Gauze (CG). Previous work has shown that hydrophobically modified chitosan (hm-C) has significant hemostatic capability relative to its native chitosan counterpart. This work aims to evaluate gauze coated in hm-C relative to CG as well as ChitoGauze (ChG) in a lethal in vivo hemorrhage model.
Source: Journal of Surgical Research - July 26, 2016 Category: Surgery Authors: Apurva Chaturvedi, Matthew B. Dowling, John P. Gustin, Thomas M. Scalea, Srinivasa R. Raghavan, Jason D. Pasley, Mayur Narayan Source Type: research
Evaluation of Lymphorrhea and Incidence of Lymphoceles: 4DryField® PH in Radical Retropubic Prostatectomy.
Conclusion. Application of 4DF on lymph node dissection areas lessened total drain loss and significantly lowered high volume drain loss. Furthermore, 4DF reduced frequency of late lymphoceles and lymphoceles requiring treatment by half, as well as duration of percutaneous drainage by more than two-thirds.
PMID: 27418927 [PubMed]
Source: Advances in Urology - July 16, 2016 Category: Urology & Nephrology Tags: Adv Urol Source Type: research
Utilization of the Track Embolization Technique to Improve the Safety of Percutaneous Lung Biopsy and/or Fiducial Marker Placement
To describe and present outcomes of the track embolization technique with absorbable hemostat-gelatin-powder during percutaneous CT-guided lung biopsy and/or fiducial marker placement versus the standard of care (no track embolization) in an attempt to decrease rates of pneumothorax (PTX), chest tube placement, hemorrhage and/or complications, and average cost-per patient.
Source: Clinical Imaging - June 16, 2016 Category: Radiology Authors: Amanjit S. Baadh, Jason C. Hoffmann, Ahmed Fadl, Dipan Danda, Vijay R. Bhat, Nicholas Georgiou, Man Hon Source Type: research
Arch Therapeutics raises $3.4m to support novel blood control dev
Arch Therapeutics (OTC:ARTH) said last week it raised $3.4 million through the private placement of the company’s securities with a group of investors.
The Framingham, Mass.-based company said it floated approximately 9.5 million shares at 36¢ per share in the placement round.
Each unit offered in the round includes 1 share of common stock and 1 Series E warrant to purchase 3/4 of a share of common stock at 44¢ per share for up to 5 years. The company said it expects to offer approximately 7.1 million Series E warrants along with the 9.5 million shares, according to a press release.
Maxim Group acted as the placeme...
Source: Mass Device - May 31, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Blood Management Business/Financial News Arch Therapeutics Source Type: news
Biom’Up announced it has received FDA clearance for the HEMOBLASTTM Bellows IDE pivotal clinical trial design
The prospective, randomized, controlled, multi-center clinical investigation evaluates the safety and efficacy of HEMOBLASTTM Bellows, the company’s novel hemostat, in cardiothoracic, abdominal, and orthopedic lower extremity surgeries. The study meets the FDA requirement for reliability by establishing the eligibility of the target bleeding site and achievement of hemostasis based on the SPOT GRADETM, a validated Surface Bleeding Severity Scale (SBSS), that is a proprietary creation of Biom’Up.
Hemorrhage is associated with approximately 37% of deaths after trauma, including mortality in the field as well as in hospit...
Source: Mass Device - May 16, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Biom'Up Source Type: news
Household Cyanoacrylate is an Efficient and Safe Adhesive for Urgent Repair of Cerebrospinal Leaks
Conclusion: Cyanoacrylate adhesive seems to be an efficient and safe alternative for the prevention of low-pressure CSF leaks.
Source: Neurosurgery Quarterly - April 30, 2016 Category: Neurosurgery Tags: Original Articles Source Type: research
Ultrasound: Foreign Body Removal
Part 2 in a SeriesAre you ready for summer? That means more bare feet, flip-flops, and the potential for foreign bodies of the foot and toe. We will continue to highlight tools and tricks to help you master soft tissue foreign body removal in the emergency department. A refresher on the basics of ultrasound is available in our blog post from last month: http://emn.online/1UGtduz.Foreign bodies of the toe or foot are common presentations in emergency departments, and one way to determine the size and shape of retained superficial foreign bodies is to use ultrasound and the linear probe. This simple technique may hel...
Source: The Procedural Pause - April 1, 2016 Category: Emergency Medicine Tags: Blog Posts Source Type: blogs
Arch Therapeutics launches EU trial for AC5 hemostat
Arch Therapeutics (OTC:ARTH) said today that it launched a European safety-and-efficacy study of its AC5 surgical hemostat in bleeding wounds incurred during dermatology procedures.
Framingham, Mass.-based Arch, which won approval for the randomized, controlled, single-blind study last December, said the 46-patient trial will include a 10-subject arm who are taking blood thinners. Each patient will have at least 2 lesions removed, with 1 wound treated using the AC5 hemostat and the 2nd with a control treatment. Arch bills AC5 as designed to stop bleeding in seconds, rather than minutes, and conform to wound geometries wh...
Source: Mass Device - March 7, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Clinical Trials Surgical Arch Therapeutics Source Type: news
